Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.540
-0.030 (-0.84%)
At close: Jan 30, 2026, 4:00 PM EST
3.600
+0.060 (1.69%)
After-hours: Jan 30, 2026, 4:36 PM EST
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $302.99 million as of January 30, 2026. Its market cap has increased by 39.66% in one year.
Market Cap
302.99M
Enterprise Value
131.90M
1-Year Change
39.66%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $302.99M, an increase of 167.23%. That is a compound annual growth rate of 18.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 302.99M | -7.09% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 326.53M |
| X4 Pharmaceuticals | 323.95M |
| Aldeyra Therapeutics | 322.47M |
| Candel Therapeutics | 320.61M |
| XOMA Royalty | 317.75M |
| AC Immune | 315.63M |
| Rezolute | 309.71M |
| Immix Biopharma | 307.21M |